Answers are grounded in this paper and cite their sources.
This Commentary highlights the 36-month longitudinal study following the pilot cohort of the Innovation-Corps (I-Corps™) at the National Institutes of Health (NIH) program, which was launched in the fall 2014.Given the long timeline to commercialization for life science technologies, this interim evaluation provides an encouraging snapshot of I-Corps participants' progress.As these companies and their technologies mature, I-Corps learnings are applied to downstream company research and product lines, indicating that this entrepreneurial translational training provides lasting value for researchers.
No takes yet. Share an insight, caveat, or question.
Canaria et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: